Intramyocardial injection of SERCA2a ‐expressing lentivirus improves myocardial function in doxorubicin‐induced heart failure

ConclusionsSERCA2a gene transfer significantly improves left ventricle function and dimensions in doxorubicin‐induced cardiomyopathy, thus making LV‐SERCA2a gene transfer an attractive treatment modality for doxorubicin‐induced heart failure. Copyright © 2016 John Wiley & Sons, Ltd.

Source: The Journal of Gene Medicine - July 4, 2016 Category: Genetics & Stem Cells Authors: Minttu Mattila, Juha Koskenvuo, Mirva S öderström, Kim Eerola, Mikko Savontaus Tags: Research Article Source Type: research